A Study of SC10914 in Patients With Advanced Solid Tumors

NCT02940132 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SC10914

Sponsor

Jiangxi Qingfeng Pharmaceutical Co. Ltd.